• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲状腺激素及其类似物调节脂代谢的新途径。

New avenues for regulation of lipid metabolism by thyroid hormones and analogs.

机构信息

Dipartimento di Scienze e Tecnologie Ambientali, Biologiche e Farmaceutiche, Seconda Università degli Studi di Napoli Caserta, Italy.

出版信息

Front Physiol. 2014 Dec 5;5:475. doi: 10.3389/fphys.2014.00475. eCollection 2014.

DOI:10.3389/fphys.2014.00475
PMID:25538628
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4256992/
Abstract

Weight loss due to negative energy balance is a goal in counteracting obesity and type 2 diabetes mellitus. The thyroid is known to be an important regulator of energy metabolism through the action of thyroid hormones (THs). The classic, active TH, 3,5,3'-triiodo-L-thyronine (T3) acts predominantly by binding to nuclear receptors termed TH receptors (TRs), that recognize TH response elements (TREs) on the DNA, and so regulate transcription. T3 also acts through "non-genomic" pathways that do not necessarily involve TRs. Lipid-lowering therapies have been suggested to have potential benefits, however, the establishment of comprehensive therapeutic strategies is still awaited. One drawback of using T3 in counteracting obesity has been the occurrence of heart rhythm disturbances. These are mediated through one TR, termed TRα. The end of the previous century saw the exploration of TH mimetics that specifically bind to TR beta in order to prevent cardiac disturbances, and TH derivatives such as 3,5-diiodo-L-thyronine (T2), that possess interesting biological activities. Several TH derivatives and functional analogs have low affinity for the TRs, and are suggested to act predominantly through non-genomic pathways. All this has opened new perspectives in thyroid physiology and TH derivative usage as anti-obesity therapies. This review addresses the pros and cons of these compounds, in light of their effects on energy balance regulation and on lipid/cholesterol metabolism.

摘要

体重减轻是通过负能平衡实现的,这是对抗肥胖和 2 型糖尿病的目标。甲状腺通过甲状腺激素(TH)的作用,是能量代谢的重要调节剂。经典的、活跃的 TH,3,5,3'-三碘-L-甲状腺素(T3)主要通过与核受体(称为 TH 受体(TRs))结合来发挥作用,这些受体识别 DNA 上的 TH 反应元件(TREs),从而调节转录。T3 还通过不涉及 TRs 的“非基因组”途径发挥作用。降脂治疗被认为具有潜在的益处,然而,全面的治疗策略仍有待建立。在对抗肥胖中使用 T3 的一个缺点是出现心律不齐。这些是通过一种称为 TRα 的 TR 介导的。上世纪末,人们探索了 TH 拟似物,这些拟似物专门与 TRβ结合,以防止心脏紊乱,以及具有有趣生物学活性的 TH 衍生物,如 3,5-二碘-L-甲状腺素(T2)。几种 TH 衍生物和功能类似物对 TR 的亲和力较低,被认为主要通过非基因组途径发挥作用。所有这些都为甲状腺生理学和 TH 衍生物作为抗肥胖疗法的应用开辟了新的前景。鉴于这些化合物对能量平衡调节和脂质/胆固醇代谢的影响,本文综述了这些化合物的优缺点。

相似文献

1
New avenues for regulation of lipid metabolism by thyroid hormones and analogs.甲状腺激素及其类似物调节脂代谢的新途径。
Front Physiol. 2014 Dec 5;5:475. doi: 10.3389/fphys.2014.00475. eCollection 2014.
2
Metabolic effects of thyroid hormone derivatives.甲状腺激素衍生物的代谢效应。
Thyroid. 2008 Feb;18(2):239-53. doi: 10.1089/thy.2007.0248.
3
Proteomic approaches for the study of tissue specific effects of 3,5,3'-triiodo-L-thyronine and 3,5-diiodo-L-thyronine in conditions of altered energy metabolism.蛋白质组学方法用于研究在能量代谢改变的情况下,3,5,3'-三碘-L-甲状腺原氨酸和3,5-二碘-L-甲状腺原氨酸的组织特异性效应。
Front Physiol. 2014 Dec 17;5:491. doi: 10.3389/fphys.2014.00491. eCollection 2014.
4
Nonalcoholic Fatty Liver Disease and Hypercholesterolemia: Roles of Thyroid Hormones, Metabolites, and Agonists.非酒精性脂肪性肝病与高胆固醇血症:甲状腺激素、代谢物和激动剂的作用。
Thyroid. 2019 Sep;29(9):1173-1191. doi: 10.1089/thy.2018.0664.
5
Genomic and Non-Genomic Mechanisms of Action of Thyroid Hormones and Their Catabolite 3,5-Diiodo-L-Thyronine in Mammals.甲状腺激素及其代谢产物 3,5-二碘-L-甲状腺原氨酸在哺乳动物中的基因组和非基因组作用机制。
Int J Mol Sci. 2020 Jun 10;21(11):4140. doi: 10.3390/ijms21114140.
6
Role of thyroid receptor β in lipid metabolism.甲状腺受体β在脂质代谢中的作用。
Biochim Biophys Acta. 2011 Aug;1812(8):929-37. doi: 10.1016/j.bbadis.2010.12.019. Epub 2010 Dec 29.
7
Thyroid hormone availability and activity in avian species: a review.鸟类甲状腺激素的可利用性与活性:综述
Domest Anim Endocrinol. 2005 Jul;29(1):63-77. doi: 10.1016/j.domaniend.2005.02.028. Epub 2005 Apr 7.
8
Both 3,5-Diiodo-L-Thyronine and 3,5,3'-Triiodo-L-Thyronine Prevent Short-term Hepatic Lipid Accumulation via Distinct Mechanisms in Rats Being Fed a High-Fat Diet.3,5-二碘-L-甲状腺原氨酸和3,5,3'-三碘-L-甲状腺原氨酸通过不同机制预防高脂饮食喂养大鼠的短期肝脏脂质积累。
Front Physiol. 2017 Sep 14;8:706. doi: 10.3389/fphys.2017.00706. eCollection 2017.
9
Differential effects of 3,5-T2 and T3 on the gill regeneration and metamorphosis of the (axolotl).3,5-T2 和 T3 对 (蝾螈)鳃再生和变态的差异影响。
Front Endocrinol (Lausanne). 2023 Jul 10;14:1208182. doi: 10.3389/fendo.2023.1208182. eCollection 2023.
10
Thyroid hormone analogues and derivatives: Actions in fatty liver.甲状腺激素类似物及衍生物:在脂肪肝中的作用
World J Hepatol. 2014 Mar 27;6(3):114-29. doi: 10.4254/wjh.v6.i3.114.

引用本文的文献

1
Bioenergetic Aspects of Mitochondrial Actions of Thyroid Hormones.甲状腺激素对线粒体作用的生物能量学方面。
Cells. 2022 Mar 15;11(6):997. doi: 10.3390/cells11060997.
2
The Role of Thyroid Disorders, Obesity, Diabetes Mellitus and Estrogen Exposure as Potential Modifiers for Pulmonary Hypertension.甲状腺疾病、肥胖、糖尿病和雌激素暴露作为肺动脉高压潜在调节因素的作用
J Clin Med. 2022 Feb 10;11(4):921. doi: 10.3390/jcm11040921.
3
The thyroid hormone levels and glucose and lipid metabolism in children with type 1 diabetes: a correlation analysis.

本文引用的文献

1
3,5-Diiodo-L-thyronine (3,5-t2) exerts thyromimetic effects on hypothalamus-pituitary-thyroid axis, body composition, and energy metabolism in male diet-induced obese mice.3,5-二碘-L-甲状腺素(3,5-t2)对雄性饮食诱导肥胖小鼠的下丘脑-垂体-甲状腺轴、身体成分和能量代谢发挥甲状腺刺激作用。
Endocrinology. 2015 Jan;156(1):389-99. doi: 10.1210/en.2014-1604.
2
Eprotirome in patients with familial hypercholesterolaemia (the AKKA trial): a randomised, double-blind, placebo-controlled phase 3 study.依替膦酸酯在家族性高胆固醇血症患者中的应用(AKKA 试验):一项随机、双盲、安慰剂对照的 3 期研究。
Lancet Diabetes Endocrinol. 2014 Jun;2(6):455-63. doi: 10.1016/S2213-8587(14)70006-3. Epub 2014 Feb 18.
3
1型糖尿病患儿的甲状腺激素水平与糖脂代谢:相关性分析
Transl Pediatr. 2021 Feb;10(2):276-282. doi: 10.21037/tp-20-204.
4
FGF21: An Emerging Therapeutic Target for Non-Alcoholic Steatohepatitis and Related Metabolic Diseases.成纤维细胞生长因子21:非酒精性脂肪性肝炎及相关代谢性疾病的新兴治疗靶点
Front Endocrinol (Lausanne). 2020 Dec 14;11:601290. doi: 10.3389/fendo.2020.601290. eCollection 2020.
5
The role of thyroid hormone in metabolism and metabolic syndrome.甲状腺激素在代谢及代谢综合征中的作用。
Ther Adv Endocrinol Metab. 2020 May 13;11:2042018820917869. doi: 10.1177/2042018820917869. eCollection 2020.
6
miR-22-3p is involved in gluconeogenic pathway modulated by 3,5-diiodo-L-thyronine (T2).miR-22-3p 参与了 3,5-二碘-L-甲状腺素 (T2) 调节的糖异生途径。
Sci Rep. 2019 Nov 12;9(1):16645. doi: 10.1038/s41598-019-53019-2.
7
Hepatic Transcriptomics Reveals that Lipogenesis Is a Key Signaling Pathway in Isocitrate Dehydrogenase 2 Deficient Mice.肝转录组学揭示,异柠檬酸脱氢酶 2 缺陷小鼠中脂肪生成是关键信号通路。
Genes (Basel). 2019 Sep 19;10(9):728. doi: 10.3390/genes10090728.
8
Serum zinc-α2-glycoprotein levels are elevated and correlated with thyroid hormone in newly diagnosed hyperthyroidism.新诊断的甲状腺功能亢进症患者血清锌-α2-糖蛋白水平升高,且与甲状腺激素相关。
BMC Endocr Disord. 2019 Jan 22;19(1):12. doi: 10.1186/s12902-019-0336-9.
9
Thyroid hormone: a resurgent treatment for an emergent concern.甲状腺激素:一种新兴治疗方法应对紧急问题。
Am J Physiol Lung Cell Mol Physiol. 2018 Dec 1;315(6):L945-L950. doi: 10.1152/ajplung.00336.2018. Epub 2018 Sep 27.
10
3,5-Diiodothyronine: A Novel Thyroid Hormone Metabolite and Potent Modulator of Energy Metabolism.3,5-二碘甲腺原氨酸:一种新型甲状腺激素代谢产物及能量代谢的强效调节剂。
Front Endocrinol (Lausanne). 2018 Jul 25;9:427. doi: 10.3389/fendo.2018.00427. eCollection 2018.
Hepatic nuclear corepressor 1 regulates cholesterol absorption through a TRβ1-governed pathway.
肝核受体辅助抑制因子 1 通过 TRβ1 调控的途径调节胆固醇吸收。
J Clin Invest. 2014 May;124(5):1976-86. doi: 10.1172/JCI73419. Epub 2014 Apr 8.
4
Thyroid hormone regulation of metabolism.甲状腺激素对代谢的调节。
Physiol Rev. 2014 Apr;94(2):355-82. doi: 10.1152/physrev.00030.2013.
5
Administration of 3,5-diiodothyronine (3,5-T2) causes central hypothyroidism and stimulates thyroid-sensitive tissues.三碘甲状腺原氨酸(T3)的给药会导致中枢性甲状腺功能减退,并刺激甲状腺敏感组织。
J Endocrinol. 2014 Jun;221(3):415-27. doi: 10.1530/JOE-13-0502. Epub 2014 Apr 1.
6
Thyroid: biological actions of 'nonclassical' thyroid hormones.甲状腺:“非经典”甲状腺激素的生物学作用。
J Endocrinol. 2014 Apr 22;221(2):R1-12. doi: 10.1530/JOE-13-0573. Print 2014 May.
7
SIRT1 and other sirtuins in metabolism.SIRT1及其他沉默调节蛋白在新陈代谢中的作用。
Trends Endocrinol Metab. 2014 Mar;25(3):138-45. doi: 10.1016/j.tem.2013.12.001. Epub 2013 Dec 30.
8
FoxO1 deacetylation regulates thyroid hormone-induced transcription of key hepatic gluconeogenic genes.FoxO1 的去乙酰化调节甲状腺激素诱导的关键肝糖异生基因的转录。
J Biol Chem. 2013 Oct 18;288(42):30365-30372. doi: 10.1074/jbc.M113.504845. Epub 2013 Aug 30.
9
SIRT1 is a direct coactivator of thyroid hormone receptor β1 with gene-specific actions.SIRT1 是甲状腺激素受体 β1 的直接共激活因子,具有基因特异性作用。
PLoS One. 2013 Jul 26;8(7):e70097. doi: 10.1371/journal.pone.0070097. Print 2013.
10
(Healthy) ageing: focus on iodothyronines.(健康)老龄化:关注甲状腺素。
Int J Mol Sci. 2013 Jul 4;14(7):13873-92. doi: 10.3390/ijms140713873.